GREENFIELD, Ind.--(BUSINESS WIRE)--Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzinâ„¢-CA1 (molidustat oral suspension), conditionally approved by U.S ...
(RTTNews) - The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results